Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 40 | 2022 | 893 | 5.510 |
Why?
|
| Alcoholism | 19 | 2022 | 1109 | 4.360 |
Why?
|
| Hippocampus | 20 | 2019 | 471 | 3.370 |
Why?
|
| Neuronal Plasticity | 11 | 2021 | 274 | 3.230 |
Why?
|
| Alcohol Drinking | 16 | 2022 | 805 | 2.730 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 7 | 2020 | 27 | 2.500 |
Why?
|
| Prefrontal Cortex | 15 | 2020 | 640 | 2.230 |
Why?
|
| Dendritic Spines | 8 | 2021 | 76 | 2.130 |
Why?
|
| Synapses | 7 | 2017 | 222 | 2.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 18 | 2016 | 266 | 1.870 |
Why?
|
| Neurons | 16 | 2019 | 881 | 1.780 |
Why?
|
| Substance Withdrawal Syndrome | 13 | 2019 | 435 | 1.780 |
Why?
|
| Central Nervous System Depressants | 9 | 2015 | 182 | 1.770 |
Why?
|
| Animals | 65 | 2022 | 20881 | 1.450 |
Why?
|
| Action Potentials | 7 | 2020 | 223 | 1.280 |
Why?
|
| Potassium Channels | 3 | 2018 | 55 | 1.270 |
Why?
|
| Nucleus Accumbens | 8 | 2021 | 417 | 1.220 |
Why?
|
| N-Methylaspartate | 7 | 2012 | 59 | 1.190 |
Why?
|
| Alcohol-Related Disorders | 2 | 2018 | 95 | 1.110 |
Why?
|
| Corticosterone | 4 | 2006 | 51 | 1.020 |
Why?
|
| Mice | 26 | 2022 | 8474 | 0.990 |
Why?
|
| Shal Potassium Channels | 3 | 2016 | 4 | 0.980 |
Why?
|
| Rats | 27 | 2021 | 5300 | 0.920 |
Why?
|
| Anxiety | 3 | 2022 | 422 | 0.880 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 189 | 0.800 |
Why?
|
| Behavior, Animal | 3 | 2020 | 470 | 0.790 |
Why?
|
| Mice, Inbred C57BL | 16 | 2021 | 2791 | 0.780 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2019 | 2083 | 0.780 |
Why?
|
| Excitatory Amino Acid Agonists | 5 | 2011 | 59 | 0.780 |
Why?
|
| Computational Biology | 2 | 2020 | 190 | 0.770 |
Why?
|
| Fragile X Mental Retardation Protein | 2 | 2018 | 20 | 0.740 |
Why?
|
| Cerebellum | 3 | 2006 | 103 | 0.740 |
Why?
|
| Stress, Psychological | 4 | 2021 | 824 | 0.720 |
Why?
|
| Ventral Tegmental Area | 2 | 2018 | 74 | 0.690 |
Why?
|
| Amino Acid Transport System X-AG | 2 | 2009 | 11 | 0.670 |
Why?
|
| Mood Disorders | 1 | 2020 | 132 | 0.660 |
Why?
|
| Shab Potassium Channels | 2 | 2009 | 6 | 0.650 |
Why?
|
| Kv Channel-Interacting Proteins | 2 | 2016 | 3 | 0.640 |
Why?
|
| Male | 44 | 2021 | 37321 | 0.630 |
Why?
|
| KCNQ Potassium Channels | 1 | 2018 | 8 | 0.630 |
Why?
|
| Glutamic Acid | 4 | 2021 | 332 | 0.620 |
Why?
|
| Animals, Newborn | 7 | 2010 | 396 | 0.620 |
Why?
|
| Substance-Related Disorders | 3 | 2016 | 1242 | 0.600 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 7 | 0.580 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 15 | 0.580 |
Why?
|
| Models, Animal | 2 | 2019 | 252 | 0.570 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 47 | 0.530 |
Why?
|
| Thiamine Deficiency | 2 | 2006 | 2 | 0.530 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2015 | 3 | 0.520 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2015 | 3 | 0.520 |
Why?
|
| Post-Synaptic Density | 1 | 2015 | 7 | 0.510 |
Why?
|
| Calcium Signaling | 2 | 2019 | 97 | 0.510 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 290 | 0.500 |
Why?
|
| Patch-Clamp Techniques | 7 | 2017 | 204 | 0.500 |
Why?
|
| Dendrites | 1 | 2014 | 44 | 0.490 |
Why?
|
| Neurotoxins | 2 | 2006 | 30 | 0.480 |
Why?
|
| Proteome | 1 | 2015 | 87 | 0.480 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 627 | 0.460 |
Why?
|
| Rivers | 2 | 2011 | 43 | 0.460 |
Why?
|
| Calcium | 5 | 2014 | 929 | 0.460 |
Why?
|
| In Vitro Techniques | 8 | 2015 | 765 | 0.450 |
Why?
|
| Aging | 2 | 2018 | 911 | 0.450 |
Why?
|
| Propidium | 8 | 2010 | 26 | 0.450 |
Why?
|
| Brain Chemistry | 1 | 2014 | 173 | 0.440 |
Why?
|
| Excitatory Postsynaptic Potentials | 6 | 2020 | 87 | 0.440 |
Why?
|
| Brain | 5 | 2019 | 2176 | 0.420 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 124 | 0.420 |
Why?
|
| Glucocorticoids | 2 | 2011 | 222 | 0.420 |
Why?
|
| Dopamine | 3 | 2021 | 474 | 0.410 |
Why?
|
| Polyamines | 2 | 2011 | 79 | 0.400 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2011 | 11 | 0.400 |
Why?
|
| Motor Activity | 5 | 2018 | 621 | 0.390 |
Why?
|
| Rats, Wistar | 5 | 2021 | 371 | 0.390 |
Why?
|
| Carbon Cycle | 1 | 2011 | 1 | 0.380 |
Why?
|
| Nitrogen Cycle | 1 | 2011 | 1 | 0.380 |
Why?
|
| Nitrogen | 1 | 2011 | 57 | 0.380 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 2 | 2021 | 26 | 0.370 |
Why?
|
| Organ Culture Techniques | 6 | 2010 | 122 | 0.370 |
Why?
|
| Underage Drinking | 2 | 2021 | 25 | 0.360 |
Why?
|
| Dizocilpine Maleate | 6 | 2008 | 43 | 0.360 |
Why?
|
| Excitatory Amino Acid Antagonists | 6 | 2009 | 128 | 0.360 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 1293 | 0.350 |
Why?
|
| Carbon | 1 | 2011 | 122 | 0.350 |
Why?
|
| Pyramidal Cells | 4 | 2017 | 79 | 0.350 |
Why?
|
| Affect | 2 | 2022 | 218 | 0.350 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2009 | 17 | 0.340 |
Why?
|
| Conditioning, Operant | 3 | 2015 | 241 | 0.320 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2018 | 1745 | 0.320 |
Why?
|
| Analysis of Variance | 4 | 2015 | 1040 | 0.300 |
Why?
|
| Drug Interactions | 5 | 2013 | 289 | 0.290 |
Why?
|
| Microinjections | 3 | 2018 | 130 | 0.290 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 175 | 0.280 |
Why?
|
| Astrocytes | 1 | 2009 | 270 | 0.270 |
Why?
|
| Alcohol Deterrents | 2 | 2018 | 86 | 0.270 |
Why?
|
| Phenylenediamines | 2 | 2016 | 16 | 0.270 |
Why?
|
| Membrane Transport Modulators | 2 | 2016 | 23 | 0.260 |
Why?
|
| Synaptic Transmission | 3 | 2016 | 236 | 0.260 |
Why?
|
| Carbamates | 2 | 2016 | 41 | 0.260 |
Why?
|
| Female | 16 | 2021 | 38074 | 0.260 |
Why?
|
| Signal Transduction | 3 | 2014 | 2689 | 0.260 |
Why?
|
| Potassium Channel Blockers | 2 | 2015 | 32 | 0.250 |
Why?
|
| Cytosol | 1 | 2005 | 123 | 0.250 |
Why?
|
| Choline | 1 | 2004 | 14 | 0.250 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 179 | 0.250 |
Why?
|
| Dexamethasone | 1 | 2005 | 150 | 0.240 |
Why?
|
| Drug-Seeking Behavior | 2 | 2018 | 213 | 0.240 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 187 | 0.240 |
Why?
|
| Hypoxia | 1 | 2005 | 169 | 0.240 |
Why?
|
| Behavior, Addictive | 1 | 2007 | 317 | 0.230 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2011 | 12 | 0.230 |
Why?
|
| Cerebral Cortex | 3 | 2016 | 415 | 0.230 |
Why?
|
| Glucose | 1 | 2005 | 307 | 0.230 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2003 | 21 | 0.220 |
Why?
|
| Pyrones | 1 | 2002 | 4 | 0.210 |
Why?
|
| Mifepristone | 3 | 2008 | 7 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2017 | 954 | 0.200 |
Why?
|
| Alcohol Abstinence | 1 | 2022 | 23 | 0.200 |
Why?
|
| Random Allocation | 2 | 2020 | 442 | 0.200 |
Why?
|
| Quinazolines | 1 | 2021 | 70 | 0.190 |
Why?
|
| Neuroimmunomodulation | 2 | 2019 | 16 | 0.190 |
Why?
|
| Visual Cortex | 1 | 2021 | 67 | 0.190 |
Why?
|
| Disks Large Homolog 4 Protein | 2 | 2012 | 15 | 0.180 |
Why?
|
| Recurrence | 3 | 2021 | 948 | 0.180 |
Why?
|
| Humans | 14 | 2022 | 68618 | 0.180 |
Why?
|
| Up-Regulation | 3 | 2012 | 682 | 0.180 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 163 | 0.180 |
Why?
|
| Nicotine | 1 | 2003 | 350 | 0.180 |
Why?
|
| Protein Subunits | 3 | 2015 | 99 | 0.180 |
Why?
|
| Drug Synergism | 3 | 2005 | 260 | 0.170 |
Why?
|
| Pentylenetetrazole | 2 | 2009 | 10 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 216 | 0.170 |
Why?
|
| Behavior | 1 | 2019 | 59 | 0.170 |
Why?
|
| Toluene | 1 | 2019 | 37 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2019 | 114 | 0.160 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 426 | 0.160 |
Why?
|
| Phosphorylation | 3 | 2016 | 1200 | 0.160 |
Why?
|
| Cells, Cultured | 3 | 2009 | 2673 | 0.160 |
Why?
|
| Corpus Striatum | 2 | 2019 | 279 | 0.150 |
Why?
|
| Risk-Taking | 1 | 2019 | 210 | 0.150 |
Why?
|
| Acetylation | 1 | 2018 | 94 | 0.150 |
Why?
|
| Reward | 1 | 2019 | 201 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 2550 | 0.150 |
Why?
|
| Neurotransmitter Agents | 2 | 2017 | 102 | 0.150 |
Why?
|
| Hormone Antagonists | 2 | 2008 | 6 | 0.150 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 31 | 0.140 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2017 | 4 | 0.140 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2017 | 8 | 0.140 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2017 | 51 | 0.140 |
Why?
|
| Seizures | 2 | 2009 | 279 | 0.140 |
Why?
|
| Long-Term Potentiation | 1 | 2017 | 53 | 0.140 |
Why?
|
| Mice, Inbred DBA | 1 | 2016 | 120 | 0.140 |
Why?
|
| Nerve Degeneration | 2 | 2015 | 134 | 0.140 |
Why?
|
| Membrane Proteins | 2 | 2012 | 617 | 0.130 |
Why?
|
| Decision Making | 1 | 2019 | 410 | 0.130 |
Why?
|
| Pyrithiamine | 2 | 2006 | 2 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2017 | 111 | 0.130 |
Why?
|
| Sumoylation | 1 | 2015 | 4 | 0.130 |
Why?
|
| Taste Perception | 1 | 2015 | 7 | 0.130 |
Why?
|
| Anthracenes | 1 | 2015 | 26 | 0.130 |
Why?
|
| Alcohol Withdrawal Seizures | 1 | 2015 | 12 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 167 | 0.130 |
Why?
|
| Apamin | 1 | 2015 | 13 | 0.130 |
Why?
|
| Extinction, Psychological | 1 | 2017 | 240 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 35 | 0.120 |
Why?
|
| Dipeptides | 1 | 2015 | 89 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2015 | 63 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 166 | 0.120 |
Why?
|
| Gene Products, tat | 2 | 2004 | 4 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 786 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 139 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2015 | 85 | 0.120 |
Why?
|
| Genomics | 1 | 2015 | 168 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Electric Stimulation | 1 | 2015 | 218 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2014 | 89 | 0.120 |
Why?
|
| Biogenic Amines | 1 | 2014 | 15 | 0.120 |
Why?
|
| Receptors, AMPA | 4 | 2016 | 99 | 0.120 |
Why?
|
| Coloring Agents | 2 | 2004 | 66 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2015 | 238 | 0.110 |
Why?
|
| Cell Death | 2 | 2005 | 329 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 109 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2015 | 223 | 0.110 |
Why?
|
| Hypothalamic Hormones | 1 | 2013 | 13 | 0.110 |
Why?
|
| Pituitary Hormones | 1 | 2013 | 16 | 0.110 |
Why?
|
| Melanins | 1 | 2013 | 24 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 521 | 0.110 |
Why?
|
| Receptors, Glycine | 1 | 2013 | 9 | 0.110 |
Why?
|
| Mutation | 2 | 2017 | 1213 | 0.110 |
Why?
|
| Cognition | 2 | 2014 | 513 | 0.110 |
Why?
|
| HIV-1 | 2 | 2004 | 177 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2015 | 317 | 0.100 |
Why?
|
| Glutathione | 1 | 2014 | 343 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2012 | 27 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 102 | 0.100 |
Why?
|
| Rodentia | 1 | 2011 | 27 | 0.100 |
Why?
|
| Research Personnel | 1 | 2012 | 83 | 0.100 |
Why?
|
| Benzoxazines | 1 | 2011 | 20 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.100 |
Why?
|
| Appalachian Region | 1 | 2011 | 6 | 0.100 |
Why?
|
| Naphthalenes | 1 | 2011 | 47 | 0.100 |
Why?
|
| Drug Tolerance | 1 | 2011 | 80 | 0.100 |
Why?
|
| Morpholines | 1 | 2011 | 79 | 0.100 |
Why?
|
| Greenhouse Effect | 1 | 2010 | 1 | 0.090 |
Why?
|
| Denitrification | 1 | 2010 | 1 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2011 | 150 | 0.090 |
Why?
|
| Pituitary-Adrenal System | 1 | 2011 | 138 | 0.090 |
Why?
|
| Nitrous Oxide | 1 | 2010 | 7 | 0.090 |
Why?
|
| Sleep | 1 | 2013 | 263 | 0.090 |
Why?
|
| Calcium Channel Agonists | 1 | 2010 | 18 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1667 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 68 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 271 | 0.090 |
Why?
|
| Cannabinoids | 1 | 2011 | 90 | 0.090 |
Why?
|
| Piperidines | 2 | 2008 | 123 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2014 | 718 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2010 | 128 | 0.090 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 134 | 0.090 |
Why?
|
| Environmental Monitoring | 1 | 2010 | 180 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2009 | 219 | 0.080 |
Why?
|
| Kainic Acid | 1 | 2009 | 44 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2009 | 160 | 0.080 |
Why?
|
| Protein Transport | 1 | 2009 | 280 | 0.080 |
Why?
|
| Spermidine | 1 | 2008 | 21 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2008 | 200 | 0.080 |
Why?
|
| Time Factors | 3 | 2012 | 4655 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 39 | 0.070 |
Why?
|
| Cocaine | 1 | 2012 | 555 | 0.070 |
Why?
|
| Extracellular Space | 1 | 2007 | 121 | 0.070 |
Why?
|
| Phenols | 1 | 2007 | 73 | 0.070 |
Why?
|
| Biological Transport | 1 | 2007 | 210 | 0.070 |
Why?
|
| Quinoxalines | 1 | 2007 | 78 | 0.070 |
Why?
|
| Neural Pathways | 2 | 2011 | 324 | 0.070 |
Why?
|
| Gait Ataxia | 1 | 2006 | 1 | 0.070 |
Why?
|
| Acetaldehyde | 1 | 2006 | 18 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2008 | 295 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2007 | 791 | 0.070 |
Why?
|
| Chromans | 1 | 2005 | 12 | 0.070 |
Why?
|
| Spironolactone | 1 | 2005 | 13 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 181 | 0.060 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2005 | 25 | 0.060 |
Why?
|
| Rats, Long-Evans | 2 | 2016 | 203 | 0.060 |
Why?
|
| Organic Chemicals | 1 | 2005 | 77 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2005 | 191 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2016 | 71 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 191 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 261 | 0.060 |
Why?
|
| Calbindin 1 | 1 | 2003 | 6 | 0.060 |
Why?
|
| Calbindins | 1 | 2003 | 23 | 0.060 |
Why?
|
| Antioxidants | 1 | 2005 | 304 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2003 | 144 | 0.050 |
Why?
|
| Photic Stimulation | 2 | 2014 | 229 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 659 | 0.050 |
Why?
|
| Polyploidy | 1 | 2022 | 24 | 0.050 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 62 | 0.050 |
Why?
|
| Receptors, Cholinergic | 1 | 2021 | 30 | 0.050 |
Why?
|
| Ceftriaxone | 1 | 2021 | 32 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2022 | 312 | 0.050 |
Why?
|
| Cholesterol | 1 | 2022 | 331 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 565 | 0.050 |
Why?
|
| Histones | 1 | 2021 | 111 | 0.050 |
Why?
|
| Ceramides | 1 | 2022 | 578 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 563 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2019 | 190 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2012 | 1692 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2018 | 312 | 0.040 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2017 | 25 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 6 | 0.030 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2016 | 31 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 2016 | 119 | 0.030 |
Why?
|
| Interneurons | 1 | 2016 | 70 | 0.030 |
Why?
|
| Imidazoles | 1 | 2016 | 175 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2015 | 115 | 0.030 |
Why?
|
| Piperazines | 1 | 2016 | 206 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2004 | 13 | 0.030 |
Why?
|
| Axons | 1 | 2015 | 139 | 0.030 |
Why?
|
| Calpain | 1 | 2015 | 205 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 244 | 0.030 |
Why?
|
| Delta Rhythm | 1 | 2013 | 11 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Color | 1 | 2013 | 50 | 0.030 |
Why?
|
| Glycine Agents | 1 | 2013 | 5 | 0.030 |
Why?
|
| Strychnine | 1 | 2013 | 14 | 0.030 |
Why?
|
| Picrotoxin | 1 | 2013 | 14 | 0.030 |
Why?
|
| Bicuculline | 1 | 2013 | 17 | 0.030 |
Why?
|
| GABA Antagonists | 1 | 2013 | 22 | 0.030 |
Why?
|
| Wakefulness | 1 | 2013 | 75 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2013 | 78 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2013 | 98 | 0.030 |
Why?
|
| Sleep, REM | 1 | 2013 | 93 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 567 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 213 | 0.030 |
Why?
|
| Plasmids | 1 | 2013 | 258 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 218 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 108 | 0.030 |
Why?
|
| Reflex, Righting | 1 | 2011 | 4 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 499 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 2011 | 16 | 0.020 |
Why?
|
| Ibotenic Acid | 1 | 2011 | 9 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2011 | 14 | 0.020 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 18 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 33 | 0.020 |
Why?
|
| Oxidopamine | 1 | 2011 | 42 | 0.020 |
Why?
|
| Biotin | 1 | 2011 | 28 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2011 | 77 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2010 | 13 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2013 | 418 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5717 | 0.020 |
Why?
|
| Attention | 1 | 2012 | 225 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 284 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1864 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 221 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8912 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 384 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2008 | 111 | 0.020 |
Why?
|
| Biguanides | 1 | 2004 | 4 | 0.010 |
Why?
|
| AIDS Dementia Complex | 1 | 2004 | 20 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 21403 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 483 | 0.010 |
Why?
|
| United States | 1 | 2010 | 7367 | 0.010 |
Why?
|